Premium Information is available for this item - Upgrade for $1 a day
6505-00-086-1542
Usp Levothyroxine Sodium Tablets
6505000861542 000861542 SYNTHR0ID
November 2023
9
Marketplace 6505-00-086-1542
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-086-1542 5+ Documents (More...)
Documents 6505-00-227-9826 2+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-086-1542
Usp Levothyroxine Sodium Tablets 000861542 Upgrade your Account Upgrade 6505-00-086-1542Usp Levothyroxine
SYNTHR0ID 001-0308 6505-12-344-6761 6505-19-000-5136 6505-01-596-4435 003-3026 Usp Levothyroxine Sodium
SYNTHR0ID 001-0308 6505-12-344-6761 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-003-3026 Usp Levothyroxine
SYNTHR0ID 001-0308 6505-12-344-6761 6505-19-000-5136 6505/us 6505-00-003-3026 Usp Levothyroxine Sodium
6505-19-001-0308 6505-12-344-6761 6505-19-000-5136 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-086-1542
Usp Levothyroxine Sodium Tablets 000861542 Quantity [CRLK]500.000 Tablets NATO Stock Numbers Related
to 6505-00-086-1542 6505-33-189-8614 6505-01-027-9055 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505
Usp Levothyroxine Sodium Tablets 000861542 227-9826 6505-19-001-0310 6505-01-145-8137 6505-01-313
Restrictions 6505-00-086-1542
6505-00-086-1542 is a Usp Levothyroxine Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-086-1542
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-086-1542
- Part Number
- Manufacturer
- Status
- SYNTHR0ID
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
Datasheet 6505-00-086-1542
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.100 Milligrams Levothyroxine Sodium Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500.000 Tablets
NATO Stock Numbers Related to 6505-00-086-1542
Freight Information 6505-00-086-1542
6505-00-086-1542 has freight characteristics.. 6505-00-086-1542 has a variance between NMFC and UFC when transported by rail and the description should be consulted.